€ 78.88
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Strong margins and returns
About
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIAISON XL, and LIAISON XL LAS; and molecular diagnostics platform comprising of LIAISON MDX for use in the amplification...
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair value on E
Target Price
The average target price of DIA.MI is 96 and suggests 22% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa
